<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="./datadict_v2.xsl"?><data_table id="pht000817.v4" study_id="phs000159.v4" participant_set="2" date_created="Fri Jul 13 12:06:57 2012"><variable id="phv00163798.v2"><name>TCGA ID</name><description>TCGA ID</description><type>String</type></variable><variable id="phv00073668.v4"><name>De-identified Universal Patient Number</name><description>Deidentified Subject ID</description><type>String</type></variable><variable id="phv00163799.v2"><name>WGS #</name><description>WGS #</description><type>Integer</type></variable><variable id="phv00163800.v2"><name>Completed Date</name><description>Completed Date</description><type/></variable><variable id="phv00073682.v4"><name>Primary Site of Disease</name><description>Disease status based on bone marrow</description><type/></variable><variable id="phv00073671.v4"><name>Histological Type</name><description>Medical Diagnosis</description><type/></variable><variable id="phv00163801.v2"><name>Tumor Grade</name><description>Tumor Grade</description><type/></variable><variable id="phv00073670.v4"><name>Participant Sex</name><description>Gender of participant</description><type/></variable><variable id="phv00163802.v2"><name>Year of Birth</name><description>Year Patient Was Born</description><type>Integer</type><unit>year</unit></variable><variable id="phv00073669.v4"><name>Age at Initial Banking</name><description>Age at Diagnosis</description><type/></variable><variable id="phv00163803.v2"><name>Days from Initial Banking to Death</name><description>Days from Initial Banking to Death</description><type>Integer</type><unit>days</unit></variable><variable id="phv00163804.v2"><name>Vital Status</name><description>Vital Status</description><type/></variable><variable id="phv00073672.v4"><name>Height in cm at Entry</name><description>Subject's height in cetimeters</description><type>Integer</type><unit>cm</unit></variable><variable id="phv00073673.v4"><name>Weight in kg at Entry</name><description>Subject's weight in kilograms</description><type>Integer</type><unit>kg</unit></variable><variable id="phv00073675.v4"><name>Participant Race</name><description>Subject's Race</description><type/></variable><variable id="phv00073674.v4"><name>Participant Ethnicity (Hispanic?)</name><description>Subject's Ethnicity</description><type/></variable><variable id="phv00073678.v4"><name>Prior diagnosis of prior neoplasm?</name><description>Any preceding (to study entry) malignancy</description><type/></variable><variable id="phv00163805.v2"><name>Notes with respect to prior disorder</name><description>Notes with respect to prior disorder</description><type/></variable><variable id="phv00073677.v4"><name>Any preceding (to study entry) hematologic disorder?</name><description>Any preceding (to study entry) hematologic disorder</description><type/></variable><variable id="phv00163806.v2"><name>Neoadjuvant therapy (hydroxyurea)</name><description>Was the Patient Exposed to Hydroxyurea Prior to Procurement?</description><type/></variable><variable id="phv00163807.v2"><name>Days of Hydroxyurea Treatment</name><description>Days of Hydroxyurea Treatment</description><type/></variable><variable id="phv00163808.v2"><name>Total Hydroxyurea Dose (mg), Days 0-3</name><description>Total Hydroxyurea Dose (mg), Days 0-3</description><type>Integer</type><unit>mg</unit></variable><variable id="phv00163809.v2"><name>Hydroxyurea Units</name><description>Hydroxyurea Units</description><type/></variable><variable id="phv00163810.v2"><name>Was the Patient Exposed to ATRA Prior to Procurement?</name><description>Was the Patient Exposed to ATRA Prior to Procurement?</description><type/></variable><variable id="phv00163811.v2"><name>Did Patient Receive Steroids Prior to Procurement?</name><description>Did Patient Receive Steroids Prior to Procurement?</description><type/></variable><variable id="phv00073676.v4"><name>Previous Exposure to Non-Medical Potentially Leukemogenic Agents</name><description>Previous Exposure to Non-Medical Potentially Leukemogenic Agents</description><type/></variable><variable id="phv00163812.v2"><name>Year of Last Contact</name><description>Year of Last Contact</description><type>Integer</type><unit>year</unit></variable><variable id="phv00163813.v2"><name>Days from Initial Banking to Last Contact</name><description>Days from Initial Banking to Last Contact</description><type>Integer</type><unit>days</unit></variable><variable id="phv00163814.v2"><name>Year of Death</name><description>Year of Death</description><type>Integer</type><unit>year</unit></variable><variable id="phv00163815.v2"><name>Source of Cells used for Analysis</name><description>Source of Cells used for Analysis</description><type/></variable><variable id="phv00073683.v4"><name>FAB Category for Bone Marrow</name><description>(FAB) category for bone marrow</description><type/></variable><variable id="phv00073685.v4"><name>Immunophenotype &amp; Cytochemistry: MPX</name><description>Immunophenotype and cytochemistry: MPX</description><type/></variable><variable id="phv00163816.v2"><name>Immunophenotype &amp; Cytochemistry: MPX % Positive</name><description>Immunophenotype &amp; Cytochemistry: MPX % Positive</description><type/></variable><variable id="phv00073686.v4"><name>Immunophenotype &amp; Cytochemistry: NSE</name><description>Immunophenotype &amp; Cytochemistry: NSE</description><type/></variable><variable id="phv00163817.v2"><name>Immunophenotype &amp; Cytochemistry: NSE % Positive</name><description>Immunophenotype &amp; Cytochemistry: NSE % Positive</description><type/></variable><variable id="phv00073687.v4"><name>Immunophenotype &amp; Cytochemistry: TDT</name><description>Immunophenotype &amp; Cytochemistry: TDT</description><type/></variable><variable id="phv00163818.v2"><name>Immunophenotype &amp; Cytochemistry: TDT % Positive</name><description>Immunophenotype &amp; Cytochemistry: TDT % Positive</description><type/></variable><variable id="phv00073688.v4"><name>Immunophenotype &amp; Cytochemistry: CD3</name><description>Immunophenotype &amp; Cytochemistry: CD3</description><type/></variable><variable id="phv00163819.v2"><name>Immunophenotype &amp; Cytochemistry: CD3 % Positive</name><description>Immunophenotype &amp; Cytochemistry: CD3 % Positive</description><type/></variable><variable id="phv00073689.v4"><name>Immunophenotype &amp; Cytochemistry: CD5</name><description>Immunophenotype &amp; Cytochemistry: CD5</description><type/></variable><variable id="phv00163820.v2"><name>Immunophenotype &amp; Cytochemistry: CD5 % Positive</name><description>Immunophenotype &amp; Cytochemistry: CD5 % Positive</description><type/></variable><variable id="phv00073690.v4"><name>Immunophenotype &amp; Cytochemistry: CD7</name><description>Immunophenotype &amp; Cytochemistry: CD7</description><type/></variable><variable id="phv00163821.v2"><name>Immunophenotype &amp; Cytochemistry: CD7 % Positive</name><description>Immunophenotype &amp; Cytochemistry: CD7 % Positive</description><type/></variable><variable id="phv00073691.v4"><name>Immunophenotype &amp; Cytochemistry: CD10</name><description>Immunophenotype &amp; Cytochemistry: CD10</description><type/></variable><variable id="phv00163822.v2"><name>Immunophenotype &amp; Cytochemistry: CD10 % Positive</name><description>Immunophenotype &amp; Cytochemistry: CD10 % Positive</description><type/></variable><variable id="phv00073692.v4"><name>Immunophenotype &amp; Cytochemistry: CD13</name><description>Immunophenotype &amp; Cytochemistry: CD13</description><type/></variable><variable id="phv00163823.v2"><name>Immunophenotype &amp; Cytochemistry: CD13 % Positive</name><description>Immunophenotype &amp; Cytochemistry: CD13 % Positive</description><type/></variable><variable id="phv00073693.v4"><name>Immunophenotype &amp; Cytochemistry: CD14</name><description>Immunophenotype &amp; Cytochemistry: CD14</description><type/></variable><variable id="phv00163824.v2"><name>Immunophenotype &amp; Cytochemistry: CD14 % Positive</name><description>Immunophenotype &amp; Cytochemistry: CD14 % Positive</description><type/></variable><variable id="phv00073694.v4"><name>Immunophenotype &amp; Cytochemistry: CD15</name><description>Immunophenotype &amp; Cytochemistry: CD15</description><type/></variable><variable id="phv00163825.v2"><name>Immunophenotype &amp; Cytochemistry: CD15 % Positive</name><description>Immunophenotype &amp; Cytochemistry: CD15 % Positive</description><type/></variable><variable id="phv00073695.v4"><name>Immunophenotype &amp; Cytochemistry: CD19</name><description>Immunophenotype &amp; Cytochemistry: CD19</description><type/></variable><variable id="phv00163826.v2"><name>Immunophenotype &amp; Cytochemistry: CD19 % Positive</name><description>Immunophenotype &amp; Cytochemistry: CD19 % Positive</description><type/></variable><variable id="phv00073696.v4"><name>Immunophenotype &amp; Cytochemistry: CD20</name><description>Immunophenotype &amp; Cytochemistry: CD20</description><type/></variable><variable id="phv00163827.v2"><name>Immunophenotype &amp; Cytochemistry: CD20 % Positive</name><description>Immunophenotype &amp; Cytochemistry: CD20 % Positive</description><type/></variable><variable id="phv00073697.v4"><name>Immunophenotype &amp; Cytochemistry: CD23</name><description>Immunophenotype &amp; Cytochemistry: CD23</description><type/></variable><variable id="phv00163828.v2"><name>Immunophenotype &amp; Cytochemistry: CD23 % Positive</name><description>Immunophenotype &amp; Cytochemistry: CD23 % Positive</description><type/></variable><variable id="phv00073698.v4"><name>Immunophenotype &amp; Cytochemistry: CD25</name><description>Immunophenotype &amp; Cytochemistry: CD25</description><type/></variable><variable id="phv00163829.v2"><name>Immunophenotype &amp; Cytochemistry: CD25 % Positive</name><description>Immunophenotype &amp; Cytochemistry: CD25 % Positive</description><type/></variable><variable id="phv00073699.v4"><name>Immunophenotype &amp; Cytochemistry: CD33</name><description>Immunophenotype &amp; Cytochemistry: CD33</description><type/></variable><variable id="phv00163830.v2"><name>Immunophenotype &amp; Cytochemistry: CD33 % Positive</name><description>Immunophenotype &amp; Cytochemistry: CD33 % Positive</description><type/></variable><variable id="phv00073700.v4"><name>Immunophenotype &amp; Cytochemistry: CD34</name><description>Immunophenotype &amp; Cytochemistry: CD34</description><type/></variable><variable id="phv00163831.v2"><name>Immunophenotype &amp; Cytochemistry: CD34 % Positive</name><description>Immunophenotype &amp; Cytochemistry: CD34 % Positive</description><type/></variable><variable id="phv00073701.v4"><name>Immunophenotype &amp; Cytochemistry: CD45</name><description>Immunophenotype &amp; Cytochemistry: CD45</description><type/></variable><variable id="phv00163832.v2"><name>Immunophenotype &amp; Cytochemistry: CD45 % Positive</name><description>Immunophenotype &amp; Cytochemistry: CD45 % Positive</description><type/></variable><variable id="phv00073702.v4"><name>Immunophenotype &amp; Cytochemistry: CD56</name><description>Immunophenotype &amp; Cytochemistry: CD56</description><type/></variable><variable id="phv00163833.v2"><name>Immunophenotype &amp; Cytochemistry: CD56 % Positive</name><description>Immunophenotype &amp; Cytochemistry: CD56 % Positive</description><type/></variable><variable id="phv00073703.v4"><name>Immunophenotype &amp; Cytochemistry: CD117</name><description>Immunophenotype &amp; Cytochemistry: CD117</description><type/></variable><variable id="phv00163834.v2"><name>Immunophenotype &amp; Cytochemistry: CD117 % Positive</name><description>Immunophenotype &amp; Cytochemistry: CD117 % Positive</description><type/></variable><variable id="phv00073705.v4"><name>Immunophenotype &amp; Cytochemistry: HLA-DR</name><description>Immunophenotype &amp; Cytochemistry: HLA-DR</description><type/></variable><variable id="phv00163835.v2"><name>Immunophenotype &amp; Cytochemistry: HLA-DR % Positive</name><description>Immunophenotype &amp; Cytochemistry: HLA-DR % Positive</description><type/></variable><variable id="phv00073704.v4"><name>Immunophenotype &amp; Cytochemistry: Other CD</name><description>Immunophenotype &amp; Cytochemistry: Other CD</description><type/></variable><variable id="phv00163836.v2"><name>Immunophenotype &amp; Cytochemistry: Other CD % Positive</name><description>Immunophenotype &amp; Cytochemistry: Other CD % Positive</description><type/></variable><variable id="phv00163837.v2"><name>Percent Cellularity</name><description>Percent Cellularity</description><type/><unit>%</unit></variable><variable id="phv00163838.v2"><name>WBC (x10e3 per mcl)</name><description>White blood count x 10^3 @ collection</description><type/></variable><variable id="phv00163839.v2"><name>Hb (g/dL)</name><description>Hemoglobin at collection</description><type/><unit>g/dL</unit></variable><variable id="phv00163840.v2"><name>Hct (%)</name><description>Hematocrit % at collection</description><type/><unit>%</unit></variable><variable id="phv00163841.v2"><name>Platelet x 10^3</name><description>Platelet x 10^3 at collection</description><type/></variable><variable id="phv00163842.v2"><name>Differential Count (Peripheral Blood): Blasts</name><description>Differential Count (Peripheral Blood): Blasts</description><type/></variable><variable id="phv00163843.v2"><name>Differential Count (Peripheral Blood): Promyelocytes</name><description>Differential Count (Peripheral Blood): Promyelocytes</description><type/></variable><variable id="phv00163844.v2"><name>Differential Count (Peripheral Blood): Myelocytes</name><description>Differential Count (Peripheral Blood): Myelocytes</description><type/></variable><variable id="phv00163845.v2"><name>Differential Count (Peripheral Blood): Metamyelocytes</name><description>Differential Count (Peripheral Blood): Metamyelocytes</description><type/></variable><variable id="phv00163846.v2"><name>Differential Count (Peripheral Blood): Bands</name><description>Differential Count (Peripheral Blood): Bands</description><type/></variable><variable id="phv00163847.v2"><name>Differential Count (Peripheral Blood): Segs (Neutrophils)</name><description>Differential Count (Peripheral Blood): Segs (Neutrophils)</description><type/></variable><variable id="phv00163848.v2"><name>Differential Count (Peripheral Blood): Eosinphils</name><description>Differential Count (Peripheral Blood): Eosinphils</description><type/></variable><variable id="phv00163849.v2"><name>Differential Count (Peripheral Blood): Basophils</name><description>Differential Count (Peripheral Blood): Basophils</description><type/></variable><variable id="phv00163850.v2"><name>Differential Count (Peripheral Blood): Lymphocytes</name><description>Differential Count (Peripheral Blood): Lymphocytes</description><type/></variable><variable id="phv00163851.v2"><name>Differential Count (Peripheral Blood): Monocytes</name><description>Differential Count (Peripheral Blood): Monocytes</description><type/></variable><variable id="phv00163852.v2"><name>Differential Count (Peripheral Blood): Prolymphocytes</name><description>Differential Count (Peripheral Blood): Prolymphocytes</description><type/></variable><variable id="phv00163853.v2"><name>Differential Count (Peripheral Blood): Promonocytes</name><description>Differential Count (Peripheral Blood): Promonocytes</description><type/></variable><variable id="phv00163854.v2"><name>Differential Count (Peripheral Blood): Abnormal Lymphocytes</name><description>Differential Count (Peripheral Blood): Abnormal Lymphocytes</description><type/></variable><variable id="phv00163855.v2"><name>Differential Count (Bone Marrow) % Blasts</name><description>Differential Count (Bone Marrow) % Blasts</description><type/></variable><variable id="phv00163856.v2"><name>Routine Cytogenetics Done?</name><description>Routine Cytogenetics Done?</description><type/></variable><variable id="phv00163857.v2"><name>Days from Initial Banking to Cytogenetic Testing</name><description>Days from Initial Banking to Cytogenetic Testing</description><type/></variable><variable id="phv00163858.v2"><name>Number of Metaphases</name><description>Number of Metaphases</description><type/></variable><variable id="phv00163859.v2"><name>Cytogenetic Risk Group</name><description>Cytogenetic Risk Group</description><type/></variable><variable id="phv00163860.v2"><name>Cytogenetic Abnormality: None (Normal)</name><description>Cytogenetic Abnormality: None (Normal)</description><type/></variable><variable id="phv00163861.v2"><name>Cytogenetic Abnormality: Not Tested</name><description>Cytogenetic Abnormality: Not Tested</description><type/></variable><variable id="phv00163862.v2"><name>Cytogenetic Abnormality: Complex</name><description>Cytogenetic Abnormality: Complex</description><type/></variable><variable id="phv00163863.v2"><name>Cytogenetic Abnormality: 3q-</name><description>Cytogenetic Abnormality: 3q-</description><type/></variable><variable id="phv00163864.v2"><name>Cytogenetic Abnormality: -5</name><description>Cytogenetic Abnormality: -5</description><type/></variable><variable id="phv00163865.v2"><name>Cytogenetic Abnormality: 5q-</name><description>Cytogenetic Abnormality: 5q-</description><type/></variable><variable id="phv00163866.v2"><name>Cytogenetic Abnormality: -7</name><description>Cytogenetic Abnormality: -7</description><type/></variable><variable id="phv00163867.v2"><name>Cytogenetic Abnormality: 7q -</name><description>Cytogenetic Abnormality: 7q -</description><type/></variable><variable id="phv00163868.v2"><name>Cytogenetic Abnormality: +8</name><description>Cytogenetic Abnormality: +8</description><type/></variable><variable id="phv00163869.v2"><name>Cytogenetic Abnormality: +21</name><description>Cytogenetic Abnormality: +21</description><type/></variable><variable id="phv00163870.v2"><name>Cytogenetic Abnormality: inv16</name><description>Cytogenetic Abnormality: inv16</description><type/></variable><variable id="phv00163871.v2"><name>Cytogenetic Abnormality: t(4;11)</name><description>Cytogenetic Abnormality: t(4;11)</description><type/></variable><variable id="phv00163872.v2"><name>Cytogenetic Abnormality: t(6;9)</name><description>Cytogenetic Abnormality: t(6;9)</description><type/></variable><variable id="phv00163873.v2"><name>Cytogenetic Abnormality: t(8;21)</name><description>Cytogenetic Abnormality: t(8;21)</description><type/></variable><variable id="phv00163874.v2"><name>Cytogenetic Abnormality: t(9;11)</name><description>Cytogenetic Abnormality: t(9;11)</description><type/></variable><variable id="phv00163875.v2"><name>Cytogenetic Abnormality: t(9;22)</name><description>Cytogenetic Abnormality: t(9;22)</description><type/></variable><variable id="phv00163876.v2"><name>Cytogenetic Abnormality: t(21;21)</name><description>Cytogenetic Abnormality: t(21;21)</description><type/></variable><variable id="phv00163877.v2"><name>Cytogenetic Abnormality: t(15;17)</name><description>Cytogenetic Abnormality: t(15;17)</description><type/></variable><variable id="phv00163878.v2"><name>Cytogenetic Abnormality: Other</name><description>Cytogenetic Abnormality: Other</description><type/></variable><variable id="phv00163879.v2"><name>Was FISH done?</name><description>Was FISH done?</description><type/></variable><variable id="phv00163880.v2"><name>Was FISH abnormality detected?</name><description>Was FISH abnormality detected?</description><type/></variable><variable id="phv00163881.v2"><name>Bcr-abl: For FISH tested indicate %:</name><description>Bcr-abl: For FISH tested indicate %:</description><type/><unit>%</unit></variable><variable id="phv00163882.v2"><name>Pml-rar: For FISH tested indicate %:</name><description>Pml-rar: For FISH tested indicate %:</description><type/><unit>%</unit></variable><variable id="phv00163883.v2"><name>MLL: For FISH tested indicate %:</name><description>MLL: For FISH tested indicate %:</description><type/><unit>%</unit></variable><variable id="phv00163884.v2"><name>CBFB: For FISH tested indicate %:</name><description>CBFB: For FISH tested indicate %:</description><type/><unit>%</unit></variable><variable id="phv00163885.v2"><name>AML1-ETO: For FISH tested indicate %:</name><description>AML1-ETO: For FISH tested indicate %:</description><type/><unit>%</unit></variable><variable id="phv00163886.v2"><name>TEL-AML1: For FISH tested indicate %:</name><description>TEL-AML1: For FISH tested indicate %:</description><type/><unit>%</unit></variable><variable id="phv00163887.v2"><name>+8: For FISH tested indicate %:</name><description>+8: For FISH tested indicate %:</description><type/><unit>%</unit></variable><variable id="phv00163888.v2"><name>-7: For FISH tested indicate %:</name><description>-7: For FISH tested indicate %:</description><type/><unit>%</unit></variable><variable id="phv00163889.v2"><name>-5: For FISH tested indicate %:</name><description>-5: For FISH tested indicate %:</description><type/><unit>%</unit></variable><variable id="phv00163890.v2"><name>Other: For FISH tested indicate %:</name><description>Other: For FISH tested indicate %:</description><type/><unit>%</unit></variable><variable id="phv00163891.v2"><name>Was Molecular Studies Done?</name><description>Was Molecular Studies Done?</description><type/></variable><variable id="phv00163892.v2"><name>Type of analysis for Molecular Study</name><description>Type of analysis for Molecular Study</description><type/></variable><variable id="phv00163893.v2"><name>Was Molecular Studies abnormality detected?</name><description>Was Molecular Studies abnormality detected?</description><type/></variable><variable id="phv00073707.v4"><name>Bcr-abl:  Molecular Studies abnormality</name><description>Molecular study abnormality: BCR-ABL (breakpoint cluster region-Abelson murine leukemia viral oncogene homolog 1)</description><type/></variable><variable id="phv00073708.v4"><name>Pml-rar:  Molecular Studies abnormality</name><description>Molecular study abnormality: PML-RAR (promyelocytic leukemia-retinoic acid receptor alpha)</description><type/></variable><variable id="phv00163894.v2"><name>FLT3 Mutation:  Molecular Studies abnormality</name><description>Molecular study abnormality: FLT3 (FMS-like tyrosine kinase 3)</description><type/></variable><variable id="phv00163895.v2"><name>Molecular Study Abnormality: DNMT3A</name><description>Molecular Study Abnormality: DNMT3A</description><type/></variable><variable id="phv00163896.v2"><name>Molecular Study Abnormality: FLT3</name><description>Molecular Study Abnormality: FLT3</description><type/></variable><variable id="phv00163897.v2"><name>Molecular Study Abnormality: IDH1</name><description>Molecular Study Abnormality: IDH1</description><type/></variable><variable id="phv00163898.v2"><name>Molecular Study Abnormality: IDH2</name><description>Molecular Study Abnormality: IDH2</description><type/></variable><variable id="phv00163899.v2"><name>Molecular Study Abnormality: KRAS</name><description>Molecular Study Abnormality: KRAS</description><type/></variable><variable id="phv00163900.v2"><name>Molecular Study Abnormality: NPM1</name><description>Molecular Study Abnormality: NPM1</description><type/></variable><variable id="phv00163901.v2"><name>Molecular Study Abnormality: NRAS</name><description>Molecular Study Abnormality: NRAS</description><type/></variable><variable id="phv00163902.v2"><name>Molecular Study Abnormality: TET2</name><description>Molecular Study Abnormality: TET2</description><type/></variable><variable id="phv00163903.v2"><name>Performance Status Scale: Karnofsky Score</name><description>Performance Status Scale: Karnofsky Score</description><type/></variable><variable id="phv00163904.v2"><name>Performance Status Scale: Eastern Cooperative Oncology Group (ECOG)</name><description>Performance Status Scale: Eastern Cooperative Oncology Group (ECOG)</description><type/></variable><variable id="phv00163905.v2"><name>Performance Status Scale: Timing</name><description>Performance Status Scale: Timing</description><type/></variable><variable id="phv00163906.v2"><name>Is this a Prospective Tissue Collection?</name><description>Is this a Prospective Tissue Collection?</description><type/></variable><variable id="phv00073679.v4"><name>Hematologic disorder and malignancy condition</name><description>Hematologic disorder and malignancy condition</description><type/></variable><variable id="phv00073680.v4"><name>Hematologic disorder and malignancy treatment</name><description>Hematologic disorder and malignancy treatment</description><type/></variable><variable id="phv00073681.v4"><name>Disease status at initial encounter</name><description>Disease status at initial encounter</description><type/></variable><variable id="phv00073684.v4"><name>Immunophenotype and cytochemistry: NA</name><description>Immunophenotype and cytochemistry: NA</description><type/></variable><variable id="phv00073706.v4"><name>Cytogenetic abnormalities</name><description>Cytogenetic abnormalities</description><type/></variable><variable id="phv00073710.v4"><name>Molecular study abnormality: Other</name><description>Molecular study abnormality: Other</description><type/></variable><variable id="phv00163907.v2"><name>Cytogenetic Abnormality: 20q-</name><description>Cytogenetic Abnormality: 20q-</description><type/></variable><variable id="phv00163908.v2"><name>Cytogenetic Abnormality: -Y</name><description>Cytogenetic Abnormality: -Y</description><type/></variable></data_table>
